ClinicalTrials.Veeva

Menu

Monitoring Radiation Induced Cardiac Damage by Blood Markers (CARD)

U

University Medical Center Groningen (UMCG)

Status

Completed

Conditions

Radiation Induced Cardiac Damage

Treatments

Other: Blood sampling

Study type

Observational

Funder types

Other

Identifiers

NCT02481778
RT2014-01

Details and patient eligibility

About

Rationale:

Radiation induced cardiac toxicity after treatment for intrathoracic tumours is a clinically relevant problem. So far, no clinical prediction models exist for cardiac toxicity. In particular, the relationship between radiation dose parameters and the risk of cardiac toxicity remains to be determined.

Clinical prediction models for cardiac toxicity are difficult to obtain, e.g. due to long latency time. Therefore, objective surrogate markers, for cardiac toxicity such as NT pro BNP and hs-TNT, as obtained during and after treatment may be of great value.

Objective:

The main objective to find a correlation between the rise in NT pro BNP level and the radiation dose given to the heart.

Enrollment

96 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically proven oesophageal- or lung cancer (adeno-, or squamous cell carcinoma or other NSCLC type)
  • Older than 18 years
  • Written informed consent

Exclusion criteria

  • Prior radiotherapy to the chest including radiotherapy for breast cancer
  • Patients treated with palliative intent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems